| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/04/2013 | WO2013101590A1 Method of detecting a salmonella microorganism |
| 07/04/2013 | WO2013101530A1 Method of detecting a salmonella microorganism |
| 07/04/2013 | WO2013101290A1 Methods of using telomeres as markers for aging |
| 07/04/2013 | WO2013101276A2 Diagnosis and detection of disease conditions modulated by activation of the sphingolipid pathway |
| 07/04/2013 | WO2013100572A1 Apparatus and method for managing genetic information |
| 07/04/2013 | WO2013100251A1 Screening methods for anticancer agents by examining the extent of methylation of pontin |
| 07/04/2013 | WO2013098797A2 Diagnostic tests for predicting prognosis, recurrence, resistance or sensitivity to therapy and metastatic status in cancer |
| 07/04/2013 | WO2013098562A2 Enzyme method |
| 07/04/2013 | WO2013098561A1 Method for characterising a polynucelotide by using a xpd helicase |
| 07/04/2013 | WO2013097868A1 Detection of adenomas of the colon or rectum |
| 07/04/2013 | WO2013097173A1 Method and primer set for detecting mutation |
| 07/04/2013 | WO2013074044A8 Methods for diagnosis and/or prognosis of gynecological cancer |
| 07/04/2013 | WO2013071450A9 A method for assaying the activity of spermidine/spermine n1-acetyltrasferase |
| 07/04/2013 | WO2013070943A3 Small molecule screen for inhibitors of nfat:ap-1:dna interactions |
| 07/04/2013 | WO2013058578A3 System for screening skin-whitening material |
| 07/04/2013 | WO2013058572A3 Hydrogel patterning and transferring method of cells, and cell-based biosensor using same |
| 07/04/2013 | WO2013056211A3 Telomerase reverse transcriptase deficience as diagnostic marker of myelodysplastic syndrome |
| 07/04/2013 | WO2013025261A9 Fluorogenic peptide probes and assays |
| 07/04/2013 | WO2013019075A3 Method of preparing nucleic acid molecules |
| 07/04/2013 | WO2012178188A3 Molecular diagnostic panel of eosinophilic gastrointestinal disorders |
| 07/04/2013 | WO2012168803A3 Providing nucleotide sequence data |
| 07/04/2013 | WO2012162460A3 Genes dysregulated in autism as biomarkers and targets for therapeutic pathways |
| 07/04/2013 | WO2012047589A3 Assay methods using nicking endonucleases |
| 07/04/2013 | US20130172430 Prognosis and treatment of breast cancer |
| 07/04/2013 | US20130172361 Assays and methods for selecting a treatment regimen for a subject with depression |
| 07/04/2013 | US20130172309 Compositions and methods for the identification of a carbapanemase gene |
| 07/04/2013 | US20130172263 Vh4 codon signature for multiple sclerosis |
| 07/04/2013 | US20130172253 Method of diagnosing and treating oxidative stress-impaired wound healing |
| 07/04/2013 | US20130172216 Arrays and Methods of Use |
| 07/04/2013 | US20130172213 Ligation-based detection of genetic variants |
| 07/04/2013 | US20130172212 Ligation-based detection of genetic variants |
| 07/04/2013 | US20130172211 Ligation-based detection of genetic variants |
| 07/04/2013 | US20130172209 Method for in vitro diagnosis or prognosis of testicular cancer |
| 07/04/2013 | US20130172208 ASSESSMENT OF BONE MARROW RECOVERY BY MEASURING PLASMA EXOSOME mRNAS |
| 07/04/2013 | US20130172206 Genome-wide detection of genomic rearrangements and use of genomic rearrangements to diagnose genetic disease |
| 07/04/2013 | US20130172205 Markers of acute kidney failure |
| 07/04/2013 | US20130172203 Hybrid model for the classification of carcinoma subtypes |
| 07/04/2013 | US20130172202 Sensor and method for detection of a target substance |
| 07/04/2013 | US20130172201 Alternative nucleotide flows in sequencing-by-synthesis methods |
| 07/04/2013 | US20130172200 Method of assessing cancerous conditions and reagent for detecting gene product to be used in the method |
| 07/04/2013 | US20130172197 High throughput nucleic acid sequencing by expansion |
| 07/04/2013 | US20130171727 T1r taste receptors and genes encoding same |
| 07/04/2013 | US20130171689 Capture of micro-organisms |
| 07/04/2013 | US20130171688 Sterilisation indicator |
| 07/04/2013 | US20130171687 Development of a detection microsystem |
| 07/04/2013 | US20130171685 Method and apparatus for characterizing biological objects |
| 07/04/2013 | US20130171684 Aerosol deposition apparatus for highly controlled range of population densities on material surfaces |
| 07/04/2013 | US20130171683 Flow cytometer apparatus and method |
| 07/04/2013 | US20130171682 Cell Culture and Gradient Migration Assay Methods and Devices |
| 07/04/2013 | US20130171680 Chimeric avian-based screening system containing mammalian grafts |
| 07/04/2013 | US20130171679 Micro-Incubation Systems for Microfluidic Cell Culture and Methods |
| 07/04/2013 | US20130171678 System and method for analyzing risk or presence of organ failure |
| 07/04/2013 | US20130171671 Methods for modeling protein stability |
| 07/04/2013 | US20130171661 Assay for Identification of LRRK2 Inhibitors |
| 07/04/2013 | US20130171657 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
| 07/04/2013 | US20130171656 Detection, identification and differentiation of proteus species using the spacer region |
| 07/04/2013 | US20130171655 Novel biological detection method for dioxins in serum, and a diagnostic use therefor in metabolic syndrome and related conditions |
| 07/04/2013 | US20130171654 Dna intercalator detection |
| 07/04/2013 | US20130171653 Methods and kits for the diagnosis of prostate cancer |
| 07/04/2013 | US20130171652 Blocking Reagent and Methods for the Use Thereof |
| 07/04/2013 | US20130171651 Methods for measuring degree of cure or soldification of a composition |
| 07/04/2013 | US20130171650 Identification of fetal dna and fetal cell markers in maternal plasma or serum |
| 07/04/2013 | US20130171649 Methods and means for predicting or diagnosing diabetes or cardiovascular disorders based on micro rna |
| 07/04/2013 | US20130171648 Method for sequencing a polynucleotide template |
| 07/04/2013 | US20130171647 Predicting responses to androgen deprivation therapy |
| 07/04/2013 | US20130171646 Nanop article-oligonucleotide hybrid structures and methods of use thereof |
| 07/04/2013 | US20130171645 Genetic make-up modifies cancer outcome |
| 07/04/2013 | US20130171644 Coincidence detection |
| 07/04/2013 | US20130171643 Sequence Specific Real-Time Monitoring of Loop-Mediated Isothermal Amplification (LAMP) |
| 07/04/2013 | US20130171642 Automated analysis of circulating tumor cells |
| 07/04/2013 | US20130171641 Method and compositions for detecting epidermal growth factor receptor variant forms in cancer cells |
| 07/04/2013 | US20130171640 Solid reagent dissolving device and method of dissolving solid reagent by using the same |
| 07/04/2013 | US20130171639 Materials and methods for diagnosis, prognosis, monitoring of recurrence, and assessment of therapeutic/prophylactic treatment of pancreatobiliary cancer |
| 07/04/2013 | US20130171638 Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer |
| 07/04/2013 | US20130171637 Materials and methods for diagnosis of bladder cancer and monitoring recurrence thereof |
| 07/04/2013 | US20130171636 Method of dna sequencing by polymerisation |
| 07/04/2013 | US20130171635 Dual oligonucleotide method of nucleic acid detection |
| 07/04/2013 | US20130171634 Biomarkers for cancers responsive to modulators of hec1 activity |
| 07/04/2013 | US20130171633 Thermal reaction device and method for using the same |
| 07/04/2013 | US20130171632 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores |
| 07/04/2013 | US20130171631 Conjugates of nucleotides and method for the application thereof |
| 07/04/2013 | US20130171630 Methods of using telomeres as markers for aging |
| 07/04/2013 | US20130171628 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices |
| 07/04/2013 | US20130171626 Methods of evaluating gene expression levels |
| 07/04/2013 | US20130171622 Compositions and methods for detecting viral infection using direct-label fluorescence in situ hybridization |
| 07/04/2013 | US20130171621 Methods of in situ detection of nucleic acids |
| 07/04/2013 | US20130171620 Viral variants and methods for detecting same |
| 07/04/2013 | US20130171619 Porous membranes having a hydrophilic coating and methods for their preparation and use |
| 07/04/2013 | US20130171617 Device and method for the automated isolation and transfer of at least one microscopic sample from a sample carrier to a collecting system |
| 07/04/2013 | US20130171615 Selective lysis of cells |
| 07/04/2013 | US20130171296 Method |
| 07/04/2013 | US20130171258 Pharmaceutical composition for elevating radio-sensitivity of cancer cells, pharmaceutical composition for detecting cancer cells with radio-sensitivity, and detection method thereof |
| 07/04/2013 | US20130171191 Compositions and Methods for Enhancing Dendritic Cell Resistance to Bacterial Infection and for Enhancing the Mobility of Dendritic Cells for Dendritic Cell-Based Immunotherapy |
| 07/04/2013 | US20130171164 Compositions and methods of modulating receptor protein tyrosine phosphatases |
| 07/04/2013 | US20130171157 NOGO Receptor-Mediated Blockade of Axonal Growth |
| 07/04/2013 | US20130171150 Feline picorna virus and uses thereof |
| 07/04/2013 | US20130171134 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/04/2013 | US20130171125 Methods for the Regulation of Cellular Metabolism Through the Modulation of SIRT3 Activity |
| 07/04/2013 | US20130169645 Computer-aided visualization of expression comparison |
| 07/04/2013 | DE102007010252B4 Kontrollgene zur Normalisierung von Genexpressionsanalysedaten Control genes for normalization of gene expression data analysis |